Govil, Sachin
Mauger, Charlène
Hegde, Sanjeet
Occleshaw, Christopher J.
Yu, Xiaoyang
Perry, James C.
Young, Alistair A.
Omens, Jeffrey H.
McCulloch, Andrew D.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (T32HL105373)
National Heart Foundation of New Zealand (1695)
Health Research Council of New Zealand (17/234)
Wellcome / EPSRC Centre for Interventional and Surgical Sciences (WT203148/Z/16/Z)
National Institutes of Health,United States (R01HL121754)
American Heart Association (19AIML35120034)
Article History
Received: 13 June 2022
Accepted: 17 January 2023
First Online: 9 February 2023
Competing interests
: ADM and JHO are co-founders of, scientific advisors to, and equity holders in Insilicomed, Inc. ADM is also a co-founder of and scientific advisor to Vektor Medical, Inc. Some of their research Grants have been identified for conflict-of-interest management. The authors are required to disclose these relationships in publications acknowledging the Grant support; however, the findings reported in this study did not involve the companies in any way and have no relationship with the business activities or scientific interests of either company. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict-of-interest policies. The rest of the authors do not have any conflict-of-interest.